COMMUNIQUÉS West-GlobeNewswire

-
Daxor Corporation Announces Rise in Kit Sales, New Device Sale, and Filing of Form N-CSR for 2017 (NYSE MKT LLC: DXR)
08/03/2018 - 18:56 -
Saratoga Springs Plastic Surgeon Named 2018 “Top Doctor” in Albany, NY Metro Area
08/03/2018 - 17:42 -
Patient Home Monitoring Announces Date and Time for Quarterly Conference Call
08/03/2018 - 17:11 -
Creating Long-Term Value for Our Members
08/03/2018 - 17:00 -
OncBioMune Selects Theradex as CRO for Two Phase 2 Trials of ProscaVax for Prostate Cancer
08/03/2018 - 15:15 -
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
08/03/2018 - 15:04 -
Sanofi Completes Acquisition of Bioverativ Inc.
08/03/2018 - 15:00 -
Sanofi finalise l'acquisition de Bioverativ Inc.
08/03/2018 - 15:00 -
First-time ACC Exhibitor Konica Minolta Healthcare to Showcase PACS Functionality for Cardiac Imaging
08/03/2018 - 15:00 -
Checkpoint Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
08/03/2018 - 15:00 -
Adamis Pharmaceuticals Announces Publication of a New Human Factors Study Comparing Its Symjepi™ Epinephrine Prefilled Syringe to the Market Leading Product in the Annals of Allergy, Asthma and Immunology
08/03/2018 - 15:00 -
MRI Interventions, Inc. to Announce Fourth Quarter and Full Year 2017 Results on March 15
08/03/2018 - 15:00 -
Imaging3 Announces the Appointment of Joe Biehl as CFO
08/03/2018 - 15:00 -
Bavarian Nordic Announces Phase 2 Trial Investigating Combination of Its Immunotherapy CV301 and Nivolumab in Microsatellite Stable Colorectal Cancer
08/03/2018 - 14:59 -
Galectin Therapeutics to Present at 2nd Annual H.C. Wainwright NASH Investor Conference
08/03/2018 - 14:30 -
Agritek Holdings, Inc. Announces Purchase Order For First 10,000 Vaporizer Cartridges Under Company's MD VapeLine To California Licensed Facility
08/03/2018 - 14:30 -
EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
08/03/2018 - 14:30 -
MJ Biotech, Inc Financial Corporate Update
08/03/2018 - 14:25 -
Mexico’s COFEPRIS (Mexico’s equivalent of the FDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer
08/03/2018 - 14:19
Pages